Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01952119 · ClinicalTrials.gov registry record · NA

Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System

A NA study of Hypertension, sponsored by Kaiser Permanente.

Completed
Registry status
NA
Development phase
182
Enrollment target
1
Study location

NCT01952119 is a NA study of Hypertension that has completed, run by Kaiser Permanente. The registered enrollment target is 182 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01952119, a NA study of Hypertension, has completed, sponsored by Kaiser Permanente.

COMPLETED
Registry status
NA
Development phase
182 participants
Enrollment target
1
Study location

Study Summary

This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.

Conditions Studied

Interventions

  • OTHER Secure message reminder

Study Locations (1)

Georgia

  • Kaiser Permanente Georgia - Atlanta

Trial Details

FieldValue
Enrollment Target 182 participants
Start Date 2011-10
Est. Completion 2012-06
Phase NA

Sponsor

Kaiser Permanente

294 total trials

What the Registry Record Tells You About NCT01952119

The ClinicalTrials.gov registry entry for NCT01952119 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 182 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (95% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Secure message reminder is the first listed.

NCT01952119 reports 1 study location spanning 1 distinct geographic area - top geographies include Georgia.

Frequently Asked Questions

What is clinical trial NCT01952119 about?

NCT01952119 is a clinical study titled "Effect of a Secure Message Reminder on Hypertension Follow-up at an Integrated Health Care System". This study will assess whether adding a secure message reminder to routine care improves the percentage of patients who complete a follow-up appointment with a new, documented blood pressure reading.

What is the current status of trial NCT01952119?

This trial is currently completed. It is a NA study. The enrollment target is 182 participants. The study started on 2011-10. Estimated completion is 2012-06.

What conditions does trial NCT01952119 study?

This clinical trial studies the following conditions: Hypertension.

What interventions are being tested in trial NCT01952119?

The interventions under investigation include: Secure message reminder (OTHER).

Who is sponsoring clinical trial NCT01952119?

This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01952119 being conducted?

This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.